Full Press Release Details
CureVac N.V., T bingen, Germany
General Meeting of Shareholders, June 19, 2023
Voting results - Overview
| Agenda Item 3 | Adoption of the annual accounts over the financial year 2022 - accepted | |
| 162.009.808 | Number of shares for which valid votes were cast (= 72.37 % of the registered share capital) | |
| 161.947.876 | Yes votes | 99.99 % of the valid votes cast |
| 14.771 | No votes | 0.0 % of the valid votes cast |
| Agenda Item 5 | Release of managing directors from liability for the exercise of their duties during the financial year 2022 - accepted | |
| 162.009.808 | Number of shares for which valid votes were cast (= 72.37 % of the registered share capital) | |
| 161.888.915 | Yes votes | 99.94 % of the valid votes cast |
| 85.524 | No votes | 0.05 % of the valid votes cast |
| Agenda Item 6 | Release of supervisory directors from liability for the exercise of their duties during the financial year 2022 - accepted | |
| 162.009.828 | Number of shares for which valid votes were cast (= 72.37 % of the registered share capital) | |
| 160.595.409 | Yes votes | 99.19 % of the valid votes cast |
| 1.303.341 | No votes | 0.80 % of the valid votes cast |
| Agenda Item 7 | Appointment of Michael Brosnan as member of the Supervisory Board - accepted | |
| 162.009.808 | Number of shares for which valid votes were cast (= 72.37 % of the registered share capital) | |
| 155.332.945 | Yes votes | 95.88 % of the valid votes cast |
| 6.660.769 | No votes | 4.11 % of the valid votes cast |
| Agenda Item 8 | Appointment of the external auditor for the financial year 2024 - accepted | |
| 162.009.808 | Number of shares for which valid votes were cast (= 72.37 % of the registered share capital) | |
| 161.985.218 | Yes votes | 99.98 % of the valid votes cast |
| 19.534 | No votes | 0.01 % of the valid votes cast |